Ra Capital Management, L.P. - Director at Mineralys Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
Director
Stock Symbol
MLYS on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Ra Capital Management, L.P. since 11/5/2023

Holdings reported by Ra Capital Management, L.P. for Mineralys Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 2.98M $40.3M $13.50 Feb 12, 2024 Indirect
Pre-Funded Warrants (Right to Buy) 550K $7.42M $13.50 Feb 12, 2024 Indirect Common Stock
Stock Option 22K May 22, 2024 Indirect Common Stock

Transactions reported by Ra Capital Management, L.P. for Mineralys Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.